Jump to section
To improve clinic operations and the standard of care by harnessing the full power of data.
15% employee growth in 12 months
The MedTech boom has seen many innovations through the 2010s, and Implicity, a remote patient monitoring and cardiac data management company, has definitely had a clear lineage of growth since its founding in 2016.
Implicity develops software to monitor and analyse the information from pacemakers and cardiovascular devices to aid physicians and healthcare professionals through all stages of a patient’s treatment. However, maintaining growth on one product alone is hard, especially with so much Medtech competition. Implicity remedies this with their other product, a data analysis platform that uses AI and cloud technology to analyse the devices linked up to their aforementioned pacemaker and cardio health platform. Implicity leverages this data for use in patient management, clinical studies, and R&D.
Playing both fields of MedTech has diversified the draw for hospitals and companies to Implicity. It continues to update and diversify the double offering via updates to their systems, with the company hoping to exemplify the continued innovation that is key to MedTech company growth.
Freddie
Company Specialist at Welcome to the Jungle
Apr 2022
$23m
SERIES A
Jun 2020
$0.1m
GRANT
This company has top investors
Arnaud Rosier
(CEO)Currently Cardio Electrophysiologist at Ramsay Santé Hospital. Previously Cardiac Electrophysiologist at Groupement des Hôpitaux de l'Institut Catholique de Lille and Cardiologist at ADHP.
David Perlmutter
(Chief Innovation Officer)Previously R&D at AIRTAG, Project Manager at HITRONETIC and Research Intern at CNES.